{"id":168,"date":"2025-06-04T08:41:59","date_gmt":"2025-06-04T08:41:59","guid":{"rendered":"https:\/\/alhenascience.com\/patients-families\/"},"modified":"2025-06-12T10:56:25","modified_gmt":"2025-06-12T10:56:25","slug":"patients-families","status":"publish","type":"page","link":"https:\/\/alhenascience.com\/it\/patients-families\/","title":{"rendered":"Patients & Families"},"content":{"rendered":"

[vc_row equal_height=”yes”][vc_column width=”1\/2″][vc_column_text css=””]Liquid tumours, including acute myeloid leukemia, are life-threatening diseases inducing severe complications that profoundly affect the life of patients and families.<\/p>\n

Therapeutic options involve risks, may cause serious complications and may not be definitive.
\nAlhena Science exploits new advances in identifying tumour-specific targets to develop definitive and curative medicine, devoting all efforts in devising treatment strategies with diligence, competence, efficiency, caution, and honesty, in compliance with health authority and hospital regulations and with highest ethical standards.<\/p>\n

Patient resources:
\nwww.cancercare.org<\/a>
\nhttps:\/\/bethematch.org\/<\/a>
\nhttps:\/\/www.lls.org\/<\/a>
\nhttps:\/\/www.mskcc.org\/<\/a>[\/vc_column_text][\/vc_column][vc_column width=”1\/2″ css=”.vc_custom_1749053440913{background-image: url(https:\/\/alhenascience.com\/wp-content\/uploads\/revslider\/Mission_1e.jpg?id=34) !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}”][vc_empty_space height=”400px”][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

[vc_row equal_height=”yes”][vc_column width=”1\/2″][vc_column_text css=””]Liquid tumours, including acute myeloid leukemia, are life-threatening diseases inducing severe complications that profoundly affect the life of patients and families. Therapeutic options involve risks, may cause serious complications and may not be definitive. Alhena Science exploits new advances in identifying tumour-specific targets to develop definitive and curative medicine, devoting all efforts … Leggi tutto<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"inline_featured_image":false,"footnotes":""},"class_list":["post-168","page","type-page","status-publish"],"yoast_head":"\nPatients & Families - Alhena Science<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/alhenascience.com\/patients-families\/\" \/>\n<meta property=\"og:locale\" content=\"it_IT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Patients & Families - Alhena Science\" \/>\n<meta property=\"og:description\" content=\"[vc_row equal_height=”yes”][vc_column width=”1\/2″][vc_column_text css=””]Liquid tumours, including acute myeloid leukemia, are life-threatening diseases inducing severe complications that profoundly affect the life of patients and families. Therapeutic options involve risks, may cause serious complications and may not be definitive. Alhena Science exploits new advances in identifying tumour-specific targets to develop definitive and curative medicine, devoting all efforts ... Leggi tutto\" \/>\n<meta property=\"og:url\" content=\"https:\/\/alhenascience.com\/patients-families\/\" \/>\n<meta property=\"og:site_name\" content=\"Alhena Science\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-12T10:56:25+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tempo di lettura stimato\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/alhenascience.com\\\/patients-families\\\/\",\"url\":\"https:\\\/\\\/alhenascience.com\\\/patients-families\\\/\",\"name\":\"Patients & Families - Alhena Science\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/alhenascience.com\\\/#website\"},\"datePublished\":\"2025-06-04T08:41:59+00:00\",\"dateModified\":\"2025-06-12T10:56:25+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/alhenascience.com\\\/patients-families\\\/#breadcrumb\"},\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/alhenascience.com\\\/patients-families\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/alhenascience.com\\\/patients-families\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/alhenascience.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Patients & Families\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/alhenascience.com\\\/#website\",\"url\":\"https:\\\/\\\/alhenascience.com\\\/\",\"name\":\"Alhena Science\",\"description\":\"Towards curative medicine\",\"publisher\":{\"@id\":\"https:\\\/\\\/alhenascience.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/alhenascience.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"it-IT\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/alhenascience.com\\\/#organization\",\"name\":\"Alhena Science\",\"url\":\"https:\\\/\\\/alhenascience.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/alhenascience.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/alhenascience.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/logo-alhena-01.png\",\"contentUrl\":\"https:\\\/\\\/alhenascience.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/logo-alhena-01.png\",\"width\":267,\"height\":266,\"caption\":\"Alhena Science\"},\"image\":{\"@id\":\"https:\\\/\\\/alhenascience.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Patients & Families - Alhena Science","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/alhenascience.com\/patients-families\/","og_locale":"it_IT","og_type":"article","og_title":"Patients & Families - Alhena Science","og_description":"[vc_row equal_height=”yes”][vc_column width=”1\/2″][vc_column_text css=””]Liquid tumours, including acute myeloid leukemia, are life-threatening diseases inducing severe complications that profoundly affect the life of patients and families. Therapeutic options involve risks, may cause serious complications and may not be definitive. Alhena Science exploits new advances in identifying tumour-specific targets to develop definitive and curative medicine, devoting all efforts ... Leggi tutto","og_url":"https:\/\/alhenascience.com\/patients-families\/","og_site_name":"Alhena Science","article_modified_time":"2025-06-12T10:56:25+00:00","twitter_card":"summary_large_image","twitter_misc":{"Tempo di lettura stimato":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/alhenascience.com\/patients-families\/","url":"https:\/\/alhenascience.com\/patients-families\/","name":"Patients & Families - Alhena Science","isPartOf":{"@id":"https:\/\/alhenascience.com\/#website"},"datePublished":"2025-06-04T08:41:59+00:00","dateModified":"2025-06-12T10:56:25+00:00","breadcrumb":{"@id":"https:\/\/alhenascience.com\/patients-families\/#breadcrumb"},"inLanguage":"it-IT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/alhenascience.com\/patients-families\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/alhenascience.com\/patients-families\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/alhenascience.com\/"},{"@type":"ListItem","position":2,"name":"Patients & Families"}]},{"@type":"WebSite","@id":"https:\/\/alhenascience.com\/#website","url":"https:\/\/alhenascience.com\/","name":"Alhena Science","description":"Towards curative medicine","publisher":{"@id":"https:\/\/alhenascience.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/alhenascience.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"it-IT"},{"@type":"Organization","@id":"https:\/\/alhenascience.com\/#organization","name":"Alhena Science","url":"https:\/\/alhenascience.com\/","logo":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/alhenascience.com\/#\/schema\/logo\/image\/","url":"https:\/\/alhenascience.com\/wp-content\/uploads\/2025\/05\/logo-alhena-01.png","contentUrl":"https:\/\/alhenascience.com\/wp-content\/uploads\/2025\/05\/logo-alhena-01.png","width":267,"height":266,"caption":"Alhena Science"},"image":{"@id":"https:\/\/alhenascience.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/alhenascience.com\/it\/wp-json\/wp\/v2\/pages\/168","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alhenascience.com\/it\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/alhenascience.com\/it\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/alhenascience.com\/it\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/alhenascience.com\/it\/wp-json\/wp\/v2\/comments?post=168"}],"version-history":[{"count":3,"href":"https:\/\/alhenascience.com\/it\/wp-json\/wp\/v2\/pages\/168\/revisions"}],"predecessor-version":[{"id":301,"href":"https:\/\/alhenascience.com\/it\/wp-json\/wp\/v2\/pages\/168\/revisions\/301"}],"wp:attachment":[{"href":"https:\/\/alhenascience.com\/it\/wp-json\/wp\/v2\/media?parent=168"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}